A 52-year-old man with hypertension is started on atenolol 50 mg daily. After 2 weeks, his blood pressure remains 160/95 mmHg despite good adherence. His heart rate is 58 bpm. The physician increases the dose to 100 mg daily. After another 2 weeks, blood pressure is still 160/92 mmHg with heart rate now 52 bpm. Which pharmacodynamic principle best explains the lack of additional blood pressure reduction despite dose escalation and further heart rate reduction?

Explanation

## Pharmacodynamic Principle: Ceiling Effect **Key Point:** A ceiling effect occurs when a drug produces its maximum therapeutic response at a dose below which further dose increases do not yield additional benefit, despite continued pharmacological activity at other receptors or tissues. ### Clinical Context Atenolol is a selective β1-adrenergic antagonist. At the dose of 50 mg daily, the drug has already achieved near-maximal occupancy of cardiac β1-receptors, producing the full antihypertensive effect possible through β1-blockade alone. Increasing the dose to 100 mg does not recruit additional β1-receptors—they are already saturated. ### Why the Heart Rate Continues to Drop The continued reduction in heart rate (58 → 52 bpm) reflects **increased pharmacological activity at the same receptor**, not recruitment of new therapeutic pathways. This is a classic dissociation: - **Antihypertensive effect:** Plateaued (ceiling reached) - **Chronotropic effect:** Still dose-dependent within the β1-receptor system This occurs because: 1. Blood pressure reduction depends on a specific threshold of β1-blockade in the heart and vasculature 2. Further β1-blockade beyond this threshold does not lower pressure further 3. Heart rate, however, continues to decrease with increasing β1-occupancy ### Ceiling Effect vs. Tachyphylaxis | Feature | Ceiling Effect | Tachyphylaxis | |---------|----------------|---------------| | **Timeline** | Immediate; present from first dose | Develops over hours to days | | **Mechanism** | Receptor saturation; pharmacodynamic limit | Desensitization, downregulation, feedback | | **Reversibility** | Reversible by adding a different drug class | May persist despite dose increase or drug holiday | | **Dose response** | Plateau on dose-response curve | Rightward shift of curve over time | | **Clinical example** | β-blocker BP plateau with continued HR reduction | Nitrate tolerance after 24–48 hrs continuous use | **High-Yield:** In this case, the patient needs a **second antihypertensive agent** (e.g., ACE inhibitor, calcium channel blocker, or thiazide diuretic) to target a different pathway, not further escalation of atenolol. **Clinical Pearl:** The ceiling effect is why monotherapy often fails in hypertension—single-agent drugs hit their pharmacodynamic ceiling, and combination therapy targeting multiple mechanisms is required. ### Why Not Tachyphylaxis? Tachyphylaxis would show a rightward shift of the dose-response curve over time, with loss of effect even at the original dose. Here, the drug maintains its effect (heart rate is still dropping), just not producing additional blood pressure reduction. The timeline (2 weeks) also argues against tachyphylaxis, which typically develops within hours to days.